Identification of Bexarotene as a PPARγ Antagonist with HDX
The retinoid x receptors (RXRs) are the pharmacological target of Bexarotene, an antineoplastic agent indicated for the treatment of cutaneous T cell lymphoma (CTCL). The RXRs form heterodimers with several nuclear receptors (NRs), including peroxisome proliferator-activated receptor gamma (PPARγ),...
Saved in:
Main Authors: | David P. Marciano, Dana S. Kuruvilla, Bruce D. Pascal, Patrick R. Griffin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2015/254560 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists
by: Tamotsu Tsukahara
Published: (2012-01-01) -
Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
by: Ajit A. Kulkarni, et al.
Published: (2012-01-01) -
Mechanisms Mediating the Effects of γ-Tocotrienol When Used in Combination with PPARγ Agonists or Antagonists on MCF-7 and MDA-MB-231 Breast Cancer Cells
by: Abhita Malaviya, et al.
Published: (2013-01-01) -
Bexarotene-induced hypothyroidism and dyslipidemia; a nation-wide study
by: Katsunori Manaka, et al.
Published: (2024-08-01) -
PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
by: Robert I. Glazer, et al.
Published: (2008-01-01)